NCT06678763View on ClinicalTrials.gov

Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

May 31, 2024

Study Completion Date

June 30, 2024

Conditions
Uterine Leiomyosarcoma
Interventions
PROCEDURE

CRS-HIPEC

Patients with uterine leiomyosarcoma who received unprotected morcellation were treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with docetaxel and gemcitabine.

Trial Locations (1)

510120

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT06678763 - Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS | Biotech Hunter | Biotech Hunter